Literature DB >> 25480585

miRNA-155 modulates the malignant biological characteristics of NK/T-cell lymphoma cells by targeting FOXO3a gene.

Wei-Guo Ji1, Xu-Dong Zhang1, Xiang-Dong Sun2, Xiang-Qi Wang3, Bao-Ping Chang4, Ming-Zhi Zhang5.   

Abstract

This study investigated the effects of miRNA-155 on malignant biological characteristics of NK/T-cell lymphoma cell lines and the possible mechanism. The expression of miRNA-155 was detected in lymphoma cell lines from different sources (SNK-6, YTS, Jurkat and DOHH2) by real-time PCR. Lentiviral vectors (pLL3.7) that could overexpress or downexpress miRNA-155 were constructed. Recombinant lentiviral particles were prepared and purified, and their titers determined. The expression of miRNA-155 in the infected SNK-6 cells and the cell proliferation were detected by PCR and CCK-8, respectively. Flow cytometry was used to determine the apoptosis of infected SNK-6 cells. The target of miRNA155 was predicted from Targetscan website. The effect of miRNA155 on FOXO3a expression was examined by Western blotting. The results showed that among the human NK/T-cell lymphoma cell lines SNK-6, YTS, Jurkat and DOHH2, the expression of miRNA-155 was highest in SNK-6. The infection efficiency of the recombinant lentivirus in SNK-6 was more than 70% at multiplicity of infection (MOI) of 100. The expression of miRNA-155 was significantly increased in SNK-6 cells infected by lentivirus vectors with high expression of miRNA-155 (4 times higher than the control group), and profoundly decreased in those infected with lentiviruses with low expression of miRNA-155. The proliferation of letivirus-infected SNK-6 cells was decreased as the expression of miRNA-155 reduced. The apoptosis rate was increased with the reduction in the expression of miRNA-155. FOXO3a was found to be a possible target of miRNA155, as suggested by Targetscan website. Western blotting showed that the expression of FOXO3a was significantly elevated in SNK-6 cells with miRNA-155 inhibition. It was concluded that reduction in miRNA-155 expression can inhibit the proliferation of SNK-6 lymphoma cells and promote their apoptosis, which may be associated with regulation of FOXO3a gene.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25480585     DOI: 10.1007/s11596-014-1368-z

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  20 in total

1.  Expression of FoxO3a in clinical cases of malignant lymphoma.

Authors:  Jun-Ichiro Ikeda; Tian Tian; Yi Wang; Yumiko Hori; Keiichiro Honma; Naoki Wada; Eiichi Morii
Journal:  Pathol Res Pract       Date:  2013-08-14       Impact factor: 3.250

2.  The prognostic value of miR-21 and miR-155 in non-small-cell lung cancer: a meta-analysis.

Authors:  Yan Wang; Jinyuan Li; Liping Tong; Jingwei Zhang; Aixia Zhai; Kun Xu; Lanlan Wei; Ming Chu
Journal:  Jpn J Clin Oncol       Date:  2013-06-30       Impact factor: 3.019

3.  MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene.

Authors:  Shuai Jiang; Hong-Wei Zhang; Ming-Hua Lu; Xiao-Hong He; Yong Li; Hua Gu; Mo-Fang Liu; En-Duo Wang
Journal:  Cancer Res       Date:  2010-03-30       Impact factor: 12.701

4.  BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas.

Authors:  Joost Kluiver; Sibrand Poppema; Debora de Jong; Tjasso Blokzijl; Geert Harms; Susan Jacobs; Bart-Jan Kroesen; Anke van den Berg
Journal:  J Pathol       Date:  2005-10       Impact factor: 7.996

5.  Quantitative proteomics reveals that miR-155 regulates the PI3K-AKT pathway in diffuse large B-cell lymphoma.

Authors:  Xin Huang; Yulei Shen; Miao Liu; Chengfeng Bi; Chunsun Jiang; Javeed Iqbal; Timothy W McKeithan; Wing C Chan; Shi-Jian Ding; Kai Fu
Journal:  Am J Pathol       Date:  2012-05-18       Impact factor: 4.307

6.  MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer.

Authors:  William Kong; Lili He; Marc Coppola; Jianping Guo; Nicole N Esposito; Domenico Coppola; Jin Q Cheng
Journal:  J Biol Chem       Date:  2010-04-06       Impact factor: 5.157

7.  miR-155 and its star-form partner miR-155* cooperatively regulate type I interferon production by human plasmacytoid dendritic cells.

Authors:  Haibo Zhou; Xinfang Huang; Huijuan Cui; Xiaobing Luo; Yuanjia Tang; Shunle Chen; Li Wu; Nan Shen
Journal:  Blood       Date:  2010-09-17       Impact factor: 22.113

8.  NF-kappaB down-regulates expression of the B-lymphoma marker CD10 through a miR-155/PU.1 pathway.

Authors:  Ryan C Thompson; Melanie Herscovitch; Ian Zhao; Tyler J Ford; Thomas D Gilmore
Journal:  J Biol Chem       Date:  2010-10-14       Impact factor: 5.157

9.  Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemia.

Authors:  Yasuo Yamanaka; Hiroyuki Tagawa; Naoto Takahashi; Atsushi Watanabe; Yong-Mei Guo; Keiko Iwamoto; Junsuke Yamashita; Hirobumi Saitoh; Yoshihiro Kameoka; Norio Shimizu; Ryo Ichinohasama; Ken-ichi Sawada
Journal:  Blood       Date:  2009-07-29       Impact factor: 22.113

10.  Overexpression of miR-142-5p and miR-155 in gastric mucosa-associated lymphoid tissue (MALT) lymphoma resistant to Helicobacter pylori eradication.

Authors:  Yoshimasa Saito; Hidekazu Suzuki; Hitoshi Tsugawa; Hiroyuki Imaeda; Juntaro Matsuzaki; Kenro Hirata; Naoki Hosoe; Masahiko Nakamura; Makio Mukai; Hidetsugu Saito; Toshifumi Hibi
Journal:  PLoS One       Date:  2012-11-28       Impact factor: 3.240

View more
  5 in total

1.  Therapeutic Potential of Chemically Modified, Synthetic, Triplex Peptide Nucleic Acid-Based Oncomir Inhibitors for Cancer Therapy.

Authors:  Karishma Dhuri; Ravinder Reddy Gaddam; Ajit Vikram; Frank J Slack; Raman Bahal
Journal:  Cancer Res       Date:  2021-09-21       Impact factor: 12.701

2.  Identification of miRNA-34a and miRNA-155 as prognostic markers for mantle cell lymphoma.

Authors:  Jianxia He; Yanfeng Xi; Ning Gao; Enwei Xu; Jin Chang; Jie Liu
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

Review 3.  MiRNAs and lncRNAs in NK cell biology and NK/T-cell lymphoma.

Authors:  FengXia Gao; SiRong He; AiShun Jin
Journal:  Genes Dis       Date:  2020-08-31

4.  MicroRNA-155 is a potential molecular marker of natural killer/T-cell lymphoma.

Authors:  Xudong Zhang; Weiguo Ji; Ruixia Huang; Lifeng Li; Xinhua Wang; Ling Li; Xiaorui Fu; Zhenchang Sun; Zhaoming Li; Qingjiang Chen; Mingzhi Zhang
Journal:  Oncotarget       Date:  2016-08-16

Review 5.  Critical role of FOXO3a in carcinogenesis.

Authors:  Ying Liu; Xiang Ao; Wei Ding; Murugavel Ponnusamy; Wei Wu; Xiaodan Hao; Wanpeng Yu; Yifei Wang; Peifeng Li; Jianxun Wang
Journal:  Mol Cancer       Date:  2018-07-25       Impact factor: 27.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.